| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/19/2002 | WO2002033119A9 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/19/2002 | WO2002033096A3 Regulation of human serine-threonine protein kinase |
| 09/19/2002 | WO2002033079A3 Human g-protein coupled receptor and uses thereof |
| 09/19/2002 | WO2002029021A3 Biotechnological method for preparing carboxylic acids with a hydroxy-nitrogen heterocycle |
| 09/19/2002 | WO2002029002A3 Method for generating cloned animals using chromosome shuffling |
| 09/19/2002 | WO2002022871A3 Polymorphic bone morphogenetic protein 2 |
| 09/19/2002 | WO2002022825A9 The c. albicans tec1 gene (catec1) and the coded tec1p protein |
| 09/19/2002 | WO2002022631A3 Regulation of human pyroglutamyl peptidase-like enzyme |
| 09/19/2002 | WO2002020841A3 5-hydroxytryptamine receptor gene polymorphisms and response to treatment |
| 09/19/2002 | WO2002020805A3 Regulation of human carboxypeptidase-like enzyme |
| 09/19/2002 | WO2002018553A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | WO2002017949A9 Novel functions for dp214 |
| 09/19/2002 | WO2002014355A3 Novel mitogen activated kinase |
| 09/19/2002 | WO2002012503A8 Production in pichia pastoris yeast and system for purifying the recombinant allergen of olea europaea ole e 1 for utilization in the diagnosis and treatment of allergies |
| 09/19/2002 | WO2002012456A3 Ampk-related serine/threonine kinase, designated snark |
| 09/19/2002 | WO2002010382A9 Trp8, trp9 and trp10, markers for cancer |
| 09/19/2002 | WO2002010379A3 Modified cea and uses thereof |
| 09/19/2002 | WO2002010362A9 Methods of controlling gene expression and gene silencing |
| 09/19/2002 | WO2002007529A3 Methods for high-temperature hydrolysis of galactose-containing oligosaccharides in complex mixtures |
| 09/19/2002 | WO2002006452A3 Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
| 09/19/2002 | WO2002004953A3 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 09/19/2002 | WO2002004664A9 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumour cells |
| 09/19/2002 | WO2002004656A3 Bio-probes and use thereof |
| 09/19/2002 | WO2002004487A3 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 09/19/2002 | WO2002003072A8 A method for extracting quantitative information relating to interactions between cellular components |
| 09/19/2002 | WO2002002765A3 Chimeric promoters for controlling expression in smooth muscle cells |
| 09/19/2002 | WO2002002610A3 Secretion and trafficking molecules |
| 09/19/2002 | WO2002000870A9 Method for transfecting cells using a magnetic field |
| 09/19/2002 | WO2001096370A9 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 09/19/2002 | WO2001092566A3 Immobilized nucleic acids and uses thereof |
| 09/19/2002 | WO2001092525A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/19/2002 | WO2001092299A9 Adenovirus particles with mutagenized fiber proteins |
| 09/19/2002 | WO2001090188A9 Receptor-based interaction trap |
| 09/19/2002 | WO2001090185A3 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof |
| 09/19/2002 | WO2001088162A3 Methods and vectors for generating antibodies in avian species and uses therefor |
| 09/19/2002 | WO2001088127A3 Regulation of human follicle stimulating hormone-like g protein-coupled receptor |
| 09/19/2002 | WO2001085956A3 Lipid metabolism enzymes |
| 09/19/2002 | WO2001085208A8 Molecular antigen arrays and vaccines |
| 09/19/2002 | WO2001083783A3 In vivo loading of mhc |
| 09/19/2002 | WO2001083729A3 Vectors for ocular transduction and use thereof for genetic therapy |
| 09/19/2002 | WO2001083514A3 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof |
| 09/19/2002 | WO2001081624A9 Method for mutation detection in hiv using pol sequencing |
| 09/19/2002 | WO2001081379A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/19/2002 | WO2001080902A3 A particulate complex for administering nucleic acid into a cell |
| 09/19/2002 | WO2001079563A3 Degradable nucleic acid probes and nucleic acid detection methods |
| 09/19/2002 | WO2001077291A3 Polynucleotides encoding novel secreted proteins |
| 09/19/2002 | WO2001070386A2 Polyfunctional support material for complex nucleic acid analysis |
| 09/19/2002 | WO2001066740A3 Compositions and methods for the treatment of immune related diseases |
| 09/19/2002 | WO2001064949A3 Diagnostics and therapeutics for glaucoma |
| 09/19/2002 | WO2001060890A3 Method for preparing functionalised polyalkylenimines, composition containing same and uses thereof |
| 09/19/2002 | WO2001051518A3 Nucleic acids encoding human semaphorin proteins and use thereof |
| 09/19/2002 | WO2001046406A3 New qtl's on chromosomes x, 2, 6 and 7 of pigs |
| 09/19/2002 | WO2001036630A9 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/19/2002 | WO2001030843A9 Ligand activated transcriptional regulator proteins |
| 09/19/2002 | WO2001016342A9 Use of lentiviral vectors for antigen presentation in dendritic cells |
| 09/19/2002 | WO2001007483A9 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 09/19/2002 | WO2000071578A9 New polypeptides and their use for the rescue of fusion defective virus or retrovirus glycoproteins |
| 09/19/2002 | WO1999060109A3 Soybean gene promoters |
| 09/19/2002 | WO1997046589A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 09/19/2002 | US20020133851 Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male fertility and uses thereof in hybrid crop production |
| 09/19/2002 | US20020133850 Melon promoters for expression of transgenes in plants |
| 09/19/2002 | US20020133849 Nucleotide sequences coding enzymatic polypeptide for use in the foods, adhesives, textiles, fertilizers, medicine, cosmetics and papermaking |
| 09/19/2002 | US20020133848 Identification and characterization of an anthocyanin mutant (ANT1) in tomato |
| 09/19/2002 | US20020133847 Plant proteins |
| 09/19/2002 | US20020133846 Method for protecting plants |
| 09/19/2002 | US20020133845 Barstar gene |
| 09/19/2002 | US20020133843 Expression vector for generating animal models for use in the treatment of epilepsy, depression and hyperactivity |
| 09/19/2002 | US20020133842 Transgenic mice containing deubiquitinated enzyme gene disruptions |
| 09/19/2002 | US20020133841 Expression vector for generating animal models for use in the treatment of epilepsy, tension and pain disorders |
| 09/19/2002 | US20020133840 Expression vector for generating animal model for use in the treatment of propagation, psychological and nervous system disorders |
| 09/19/2002 | US20020133839 Expression vector for generating animal model for use in the treatment of cardiovascular and nervous system disorders |
| 09/19/2002 | US20020133838 HS-40 enhancer-containing vector |
| 09/19/2002 | US20020133837 Transgenic animals at a nuclear hormone receptor locus |
| 09/19/2002 | US20020133836 Methods to identify swine genetically resistant to F18 E. coli associated diseases |
| 09/19/2002 | US20020133835 Genetically engineering vertebrate germ cells; obtain gonads, incubate in transfection mixture and nucleotide sequences, transfect, recover transfected germ cells |
| 09/19/2002 | US20020133832 Model systems for neuordegenerative and cardiovascular disorders |
| 09/19/2002 | US20020133831 Method for identifying mutants and molecules |
| 09/19/2002 | US20020133629 Encapsulating fibre channel signals for transmission over non-fibre channel networks |
| 09/19/2002 | US20020133126 Transfection system, its preparation and use in somatic gene therapy |
| 09/19/2002 | US20020133002 Computer implemented nucleic acid isolation method and apparatus |
| 09/19/2002 | US20020133001 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 09/19/2002 | US20020133000 Neuronal protein for use in inducing sleep and for treatment of sleep disorders |
| 09/19/2002 | US20020132998 Nucleotide sequences coding channel protein for use in human therapeutics and diagnostic, cosmetics, drug screening and the development of nutrients |
| 09/19/2002 | US20020132997 Nucleotide sequences coding enzymatic polypeptide for use as amplification tool in genetic engineering |
| 09/19/2002 | US20020132995 Modulation of immune response to preferential nucleotide sequences; obtain nucleotide sequence sample, insert adjusted nucleotides, administer to mammals monitor immune response |
| 09/19/2002 | US20020132994 Nucleotide sequences coding polypeptide for use in the treatment and prevention of microorganismal infections |
| 09/19/2002 | US20020132990 Bioengineered vehicles for targeted nucleic acid delivery |
| 09/19/2002 | US20020132988 Generation preferential antibody; construct peptide library, immunize cells, isolating and purify antisera from cells |
| 09/19/2002 | US20020132979 Monoclonal antibody for use in the diagnosis, prevention and treatment of tumors |
| 09/19/2002 | US20020132978 VEGF-modulated genes and methods employing them |
| 09/19/2002 | US20020132973 Peptide parathyroid hormone analogs |
| 09/19/2002 | US20020132788 Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo |
| 09/19/2002 | US20020132786 Inhibitors of Apoptosis protein used to modulate apoptosis or to identify modulators of apoptosis as well as in therapeutic uses. |
| 09/19/2002 | US20020132775 Human potassium channel 1 and 2 proteins |
| 09/19/2002 | US20020132769 Comprising a soluble adenoviral receptor domain, a trimerization domain, and a targeting ligand domain; using molecule to treat a disease, such as cancer, with adenoviral gene therapy; side effect reduction |
| 09/19/2002 | US20020132768 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/19/2002 | US20020132753 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | US20020132500 Electrical connection structure, production method thereof, and electric wiring method |
| 09/19/2002 | US20020132350 Targeted genetic manipulation using Mu bacteriophage cleaved donor complex |
| 09/19/2002 | US20020132349 Double transposition methods for manipulating nucleic acids |